The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
Chromogranin A (CgA) is a non-specific biomarker excreted by neuroendocrine tumor (NET) cells. Elevation of circulating CgA level can be detected in gastroenteropancreatic (GEP)-NET patients and has been shown to correlate with tumor burden. The prognostic and predictive roles of CgA level and the c...
Guardado en:
Autores principales: | Hui-Jen Tsai, Chin-Fu Hsiao, Jeffrey S. Chang, Li-Tzong Chen, Ying-Jui Chao, Chia-Ju Yen, Yan-Shen Shan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5cd3260d8974337a47bcaa9143429fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan
por: Jeffrey S. Chang, et al.
Publicado: (2021) -
Relevant risk factors and the prognostic impact of positive resection margins after endoscopic resection of gastrointestinal neuroendocrine tumors
por: Jing Wen, et al.
Publicado: (2019) -
Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
por: Marta Opalińska, et al.
Publicado: (2021) -
Imaging of Neuroendocrine Prostatic Carcinoma
por: Ahmed Taher, et al.
Publicado: (2021) -
A Novel Strategy for the Diagnosis of Pulmonary High-Grade Neuroendocrine Tumor
por: Kentaro Miura, et al.
Publicado: (2021)